To view the PDF file, sign up for a MySharenet subscription.

LABAT AFRICA LIMITED - Profit Forecast for the years ending 31 August 2021 & 31 August 2022 & Capital Raising Roadshow

Release Date: 05/05/2020 15:13
Code(s): LAB     PDF:  
Wrap Text
Profit Forecast for the years ending 31 August 2021 & 31 August 2022 & Capital Raising Roadshow

Incorporated in the Republic of South Africa
(Registration number 1986/001616/06)
JSE code: LAB ISIN: ZAE000018354
(“Labat”, “the Group” or “the Company”)


During 2019 and 2020, Labat has announced its various initiatives and entry into the cannabis and
hemp industry, which it believes is the beginning of a new “100 year industry”. A number of strategic
acquisitions, relationships and people have been brought together throughout the entire value chain
from farming to retail and it is the intention of Labat to raise capital to aggressively grow this business,
which is now housed in its Labat Healthcare segment and is headed up by Mr Mike Stringer. Labat
intends raising R112 million through the issue of shares under its existing General Authority to issue
shares for cash.

The share placing will be conducted by way of a book build, which Labat believes should have the
added benefit of enhancing the liquidity of its shares. The book build will be offered to qualifying
investors only through a book build process and does not constitute, nor is intended to constitute, an
offer to the public to purchase or subscribe for any shares. A presentation containing more detail on
the book build is available on the Labat Healthcare website at

The roadshow and book build will open with immediate effect and is expected to close by 17h00 on
Friday, 26 June 2020. Pricing and allocations will be announced as soon as practicable following the
closing of the book.

Arbor Capital is assisting Labat with the roadshow and book build. For further information or to request
a presentation, please contact Michelle Krastanov on +27 (0)11 480 8570 or Kay Stoler on +27 11 480
8628, or by way of e-mail at or

In addition to the capital raising, and based on the key assumption that the required capital of
R112 million will be raised before the end of the current financial year ending 31 August 2020 and key
projects will commence before 1 September 2020, the Company has prepared profit forecasts for
the two years ending 31 August 2021 and 31 August 2022. No profit forecast has been issued for the
current year ending 31 August 2020.

The profit forecasts have not been audited or reviewed by the Company’s auditor or a Reporting
Accountant and are issued on a voluntary basis due to the intended road show.

Statement of compliance
The two year forecasts are prepared in accordance with the framework concepts and the
recognition and measurement criteria of International Financial Reporting Standards (“IFRS”), its
interpretations adopted by the International Accounting Standards Board (IASB), IAS 34 – Interim
Financial Reporting and the Listings Requirements of the JSE Limited.
Details of the profit forecast for the two years ending 31 August 2021 and 31 August 2022, together
with assumptions, as set out below:

                                                                     12 months           12 months
                                                                        Ending              Ending
                                                                31 August 2021      31 August 2022
                                                                         R’000               R’000
 Revenue                                                               935 172             512 351
 Cost of sales                                                        (762 020)           (239 288)
 Gross profit                                                          173 152             273 063
 Operating expenses                                                    (96 359)            (81 966)
 Operating profit                                                       76 793             191 097
 Finance costs                                                          (6 968)             (1 771)
 Profit before taxation                                                 69 825             189 326
 Taxation                                                               (9 624)            (26 928)
 Profit for the period                                                  60 201             162 398

 Total comprehensive Income for the
 period                                                                60 201              162 398

 Attributable to:
 Equity holders of the parent                                           57 406             157 390
 Non-controlling interest                                                2 795               5 008

 Total comprehensive income for the
 period                                                                 60 201              162 398

Headline earnings reconciliation
The headline earnings reconciliation is set out below:

                                                                         R’000               R’000
 Profit for the period attributable to equity
 holders of the parent                                                  57 406             157 390
 Headline earnings attributable to
  shareholders of the Group                                             57 406             157 390

Share information
 Basic and diluted earnings per share (cents)                             10.9                29.9
 Basic and diluted headline earnings per share (cents)                    10.9                29.9
 Weighted average shares in issue (‘000)                               526 909             526 909
 Number of shares in issue at period end                               526 909             526 909

Basis of preparation
The profit forecast has been prepared using the accounting policies of Labat used in the preparation
of the audited results for the year ended 31 August 2019 and the interim results for the six months
ended 29 February 2020. New accounting standards introduced over these two periods have been
considered as follows:

IFRS 9: Financial instruments
The standard requires financial assets to be measured either at amortized cost or fair value,
depending on the business model under which they are held and the cash flow characteristics of
the instrument. In addition, the standard replaces the incurred loss impairment model in IAS 39 with
an expected loss model. It will no longer be necessary for a credit event to have occurred before
credit losses are recognised. The profit forecast assumes a provision for credit losses at a rate of 2%
based on the estimated Trade Accounts Receivable book.

IFRS 15: Revenue from contracts with customers
The IFRS replaces IAS 18 Revenue and provides a single, principles based five-step model to be
applied to all contracts with customers. The steps involve identifying the contract, identifying the
performance obligations under the contract, determining the transaction price, allocating the
transaction price to the performance obligations in the contract, and recognising revenue when the
entity satisfies a performance obligation. The amendments have no impact on the Group’s profit
forecast and revenue has been assumed to be earned in line with historical revenue recognition.

IFRS16: Leases – Effective date: 1 January 2019
The IFRS 16 replaces IAS 17 Leases. IFRS 16 has one model for lessees which will result in almost all the
leases being included on the Statement of Financial Position. Lessors continue to classify leases as
operating or finance leases. Historically this has not had a material impact on the results of Labat.

Key Assumptions:
The assumptions utilised in the profit forecast and which are considered by management to be
significant or are key factors on which the results of the enlarged Group will depend, are disclosed
below. The assumptions disclosed are not intended to be an exhaustive list. There are other routine
assumptions, which are not listed. The actual results achieved during the forecast period may vary
from the forecast and the variations may or may not be material. The forecast financial information
is based on the assumption that circumstances which affect the Group’s business, but which are
outside the control of the Directors, will not materially alter in such a way as to affect the trading of
the Group.

1.    The current market conditions in the fuel industry in which the business operates are expected
      to change substantially pursuant to the substantial drop in demand following the COVID-19
      pandemic and drop in the oil price. Accordingly, the fuel business has been forecast on a zero-
      based approach and fuel margins will be renegotiated in line with volumes and trading
2.    The forecast numbers assume that the capital of R112 million is raised for capital expenditure
      and working capital requirements needed to grow the business. The number of shares in issue
      has been assumed to increase by 112 000 000 shares, although this number may vary.
3.    The forecast numbers have been prepared in terms of IFRS and are based on the accounting
      policies of the Group.
4.    The forecast for the twelve month period ending 31 August 2021 commences from
      1 September 2020 and will thus be fully representative of the Group.
5.    Expenses have been forecast on a line-by-line basis and reflect the current budgeted
      expenditure and takes into account the cost of being listed.
6.    The present level of interest and tax rates will remain substantially unchanged.
7.    The expected impact on financial results due to foreign exchange movement has been kept
      consistent with current ruling market conditions at an estimated average exchange rate over
      the period. These mainly relate to the ICT business SAMES and the exchange rate used was at
      a rate of 16.5:1.
8.    Interest from cash generated from operations has been taken into account in the forecasts.
9.    Depreciation expense is provided for over the useful of the assets used.
10.   Intangible assets are amortised over the expected periods in line with historical provisions made
      and assumed rates for new categories of intangible assets acquired during 2019 and 2020.
11.   Revenue is based on an estimated percentage contribution between current clients and
      expected new business.
12.   Finance Costs are assumed at commercial bank rates between 9.5% to 12%, depending on
      the different funding models and subsidiaries being funded.
13.   Interest Income is assumed at commercial bank investment rates on surplus cash of between
      5.0% to 7.2%.

Detailed assumptions


         An analysis of the revenue of the Group for the original core business and new Labat
         Healthcare business areas is set out below:

                                                                              Year                  Year
                                                                            ending                ending
                                                                    31 August 2021        31 August 2022
                                                                             R’000                 R’000
          Total Revenue                                                    935 172               512 351
          Logistics                                                         57 987                65 235
          Technology                                                        14 477                15 346
          Fuel                                                             677 519                     -
          Healthcare                                                       185 189               431 770

         It has been assumed that as the Labat Healthcare business grows, the low margin fuel
         wholesale business will be exited when global conditions improve. This is a key assumption for
         the year ending 31 August 2022. If the business is not exited, then a similar performance to that
         expected for the year ending 31 August 2021 can be assumed.

         A further analysis of the Labat Healthcare forecast revenue line is set out below:

                                                                              Year                  Year
                                                                            ending                ending
                                                                    31 August 2021        31 August 2022
                                                                            R’ 000                 R’000
          Labat Botanicals (Lesotho)                                        75 938               205 286
          Labat Pharmaceuticals                                             49 065                99 312
          Labat Hemp Processing                                                  -                36 326
          CannAfrica                                                        60 186                90 845
          Total Revenue                                                    185 189               431 770

         The Gross Profit margins for the respective business units projected are as follows:

                                                                              Year                  Year
                                                                            ending                ending
                                                                    31 August 2021        31 August 2022
          Consolidated Gross Margins                                             %                     %

          Logistics                                                          13.1%                 13.1%
          Technology                                                         68.4%                 68.5%
          Fuel                                                                8.5%                  0.0%
          Healthcare (see further analysis below)                            53.0%                 58.8%
          Other                                                               0.0%                  0.0%

          Labat Healthcare Gross Margins
          Labat Botanicals (Lesotho)                                         66.9%                 82.0%
          Labat Pharmaceuticals                                              58.8%                 40.2%
          Labat Hemp Processing                                               0.0%                 51.1%
          CannAfrica                                                         30.7%                 29.9%

         For the 2021 and 2022 period the Revenue contribution and growth ratios are as follows:

         •   The Logistics division contributes 6.1% and 12.6% respectively for the Labat Group forecast
         •   The Technology Business contributes 1.5% and 3.0% respectively for the Labat Group forecast
         •   The Fuel business contributes 71.7% and 0% respectively for the Labat Group forecast
         •  The Labat Healthcare Business contributes 19.6% and 83.2% respectively for the Labat Group
            forecast turnover.
         •  Other revenue contributes 1.1% and 1.3% respectively for the Labat Group forecast turnover.
         •  The Labat Healthcare Business are as follows:
            o the Labat Botanicals stream contributes 41% and 48% respectively for the Labat
              Healthcare forecast turnover;
            o the Labat Pharmaceuticals stream contributes 26.5% and 23% respectively for the Labat
              Healthcare forecast turnover;
            o the Labat Hemp Processing stream contributes 0% and 8.4% respectively for the Labat
              Healthcare forecast turnover due to the need to secure and develop farmers and plant
              during the first period; and
            o the CannAfrica stream contributes 32.5% and 21% respectively for the Labat Healthcare
              forecast turnover.

         The above new revenue streams for Labat include the businesses acquired or being developed
         during the 2019/20 financial years. Ramp-up has already commenced during the 2020 financial
         year in most cases and we anticipate that the programme will speed up post the lockdown
         period under COVID-19. Management has already secured new solid offtake agreements from
         both local and international clients and it is expected that sales will commence within the 2021
         FY and a full year of revenue in the 2022 FY. This is evident in the expected growth in revenue
         in Labat Botanicals for the 2022 FY.

         Revenue in the Fuel business, being the major contributor to Group turnover historically, is within
         revenue levels achieved in prior years will only be accounted for the 2021 FY as the Group will
         be considering the sale of the Fuel business during the 2021 FY, when conditions improve. The
         revenue forecast is in line with prior year revenue but focus has been given on the new uptake
         in clients which has been undertaken during the 2020 FY. The Fuel business has historically been
         a very low margin business with increased associated risks with turbulent economic conditions
         and industry challenges, which South Africa has been plagued with over recent years.

         The increase in Logistics revenue is based on an increase in new clientele during the 2020 FY.

         The ICT revenue is expected to continue at the current pace and will make way for new
         product development in line with the Healthcare business to complement Labat’s new
         strategies that have been incubated over the past year and are currently in a high growth
         phase, albeit off a very low base.

         Labat Botanicals has multiple opportunities globally though the investment in regional
         presence in both South Africa and Lesotho that will be used to serve those demands and
         exploit the opportunities.


         The main component of operational expenses is salaries and wages, representing a majority
         portion of the operational expenses. The forecast for salaries and wages for 2021 is based on
         the existing headcount, with an increase assumed in 2022 for both Labat Logistics and a
         substantial increase in headcount in the Labat Healthcare segment.

         The balance of the operational costs has been based on the existing expense base of the
         Group. The operating expenses are higher than the operating expenses for the year ended
         31 August 2019 due to the new business strategy of Labat Healthcare. This is assumed to reduce
         in 2022 due to the assumed disposal of the fuel wholesale business. Further cost savings started
         towards the end of 2019 and continued into 2020 and included renegotiating on a Group level
         various costs and contracts. Foreign exchange gains or losses have not been forecast.

         Depreciation and amortisation have been assumed on the basis of the existing depreciation
         and amortisation rates used by the Group as well as on expected capital expenditure and
         development costs, which are capitalised and then amortised. Details of the projected EBITDA,
         depreciation and amortisation as set out in the table below:

                                                                            31 August        31 August
                                                                                 2021             2022
                                                                                R’000            R’000
         EBITDA                                                               100 130          207 044
         Depreciation                                                          (2 431)          (2 431)
         Amortisation of Intangibles                                          (20 907)         (13 516)

         The amortisation of intangibles consists the following, which is consistent to those in prior years:

         • Marketing-related intangible assets;
         • Contractual and non-contractual client relationship;
         • Contract-based intangible assets; and
         • Integrated Circuits.

         No impairment of goodwill or any other assets has been assumed.

3.       TAXATION

         Taxation has been assumed at the rate of taxation in the relevant tax jurisdictions, being 10%
         in Lesotho and 28% in South Africa.


         Revenue, cost of sales and operating expenses can be influenced by director actions.


         Major restructures, regulatory, economic or political factors and the short and medium term
         impact of COVID-19 and the economic lockdown can impact on a customer or industry, which
         in turn can have an impact on the Company. Such factors are outside the influence of


         This report may contain certain forward-looking statements concerning Labat’s operations,
         economic performance and financial condition, plans and expectations. Such views involve
         both known and unknown risks, assumptions, uncertainties and other important factors that
         could materially influence the actual performance of the Group. No assurance can be given
         that these will prove to be correct and no representation or warranty expressed or implied is
         given as to the accuracy or completeness of such views or as to any of the other information
         in this report.

         The Group does not undertake to update any forward-looking statements and does not
         assume responsibility for any loss or damage, however arising, as a result of the reliance by any
         party thereon, including, but not limited to, loss of earnings, profits or consequential loss or

5 May 2020

Arbor Capital Sponsors

Date: 05-05-2020 03:13:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story